(Q37114963)

18 August 2017

1 reference

title

The economic evaluation of cancer treatments and programmes (English)

1 reference

18 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835583

6 December 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

6 December 2022

author name string

M. Goddard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835583

6 December 2022

M. Drummond

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835583

6 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1835583

6 December 2022

publication date

1 January 1991

1 reference

full work available at URL

18 August 2017

https://api.elsevier.com/content/article/PII:027753799190078R?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

https://api.elsevier.com/content/article/PII:027753799190078R?httpAccept=text/plain

6 December 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

European Journal of Cancer

6 December 2022

published in

1 reference

18 August 2017

volume

27

1 reference

18 August 2017

issue

10

1 reference

18 August 2017

page(s)

1191-1196

1 reference

A comparison of the cost of various treatment methods for early cancer of the prostate

18 August 2017

cites work

5

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

The cost effectiveness of conservative surgery for breast cancer

6 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

The cost of saving a life through cervical cytology screening: implications for health policy

6 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

Cervical-cancer screening: attendance and cost-effectiveness

6 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

The cost-effectiveness of breast cancer screening

6 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

A cost-effectiveness analysis of screening for carcinoma of the prostate by digital examination

6 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

Comparative cost analysis of hemilaryngectomy and irradiation for early glottic carcinoma

6 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

Cost effectiveness of bone marrow transplantation in acute nonlymphocytic leukemia

6 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

Cost of bone-marrow transplants in acute myeloid leukaemia

6 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

Cost-effectiveness comparison of estrogen therapy and orchidectomy in patients with prostatic cancer.

6 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

The cost of bilateral orchiectomy as a treatment for prostatic carcinoma

6 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

A randomised controlled trial of hospice care

6 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

Carboplatin versus cisplatin

6 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

Cost of outpatient chemotherapy

6 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

Counting the costs of cancer therapy

6 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

Cost-benefit determinations in screening mammography

6 December 2022

26

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

The distinction between cost and charges

6 December 2022

28

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

Screening and the costs of treating colorectal cancer: some preliminary results

6 December 2022

29

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

Cost-effectiveness of cancer chemotherapy: an economic evaluation of a randomized trial in small-cell lung cancer

6 December 2022

30

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

Breast cancer screening and health service costs

6 December 2022

31

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

Cost effectiveness of chest CT in T1N0M0 lung cancer

6 December 2022

32

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

Cost-benefit analysis of interferon alfa-2b in treatment of hairy cell leukemia

6 December 2022

34

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

Assessing quality of life in cancer patients

6 December 2022

35

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

Measuring quality of life in cancer patients

6 December 2022

36

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation

6 December 2022

37

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

The Nottingham Health Profile: subjective health status and medical consultations

6 December 2022

39

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

6 December 2022

40

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

Measurement of health state utilities for economic appraisal

6 December 2022

41

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer

6 December 2022

42

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

EuroQol--a new facility for the measurement of health-related quality of life

6 December 2022

45

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

The utility of different health states as perceived by the general public

6 December 2022

46

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

Measurement of values for states of health with linear analog scales

6 December 2022

47

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

The measurement of patients' values in medicine

6 December 2022

48

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

Quality-adjusted life years, utility theory, and healthy-years equivalents

6 December 2022

49

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

Economic evaluation of trends in cancer therapy. Marginal or average costs?

6 December 2022

51

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

Cost-effectiveness in the diagnosis and treatment of carcinoma of unknown primary origin

6 December 2022

52

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues

6 December 2022

53

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90078-R

6 December 2022

Identifiers

1 reference

18 August 2017

1 reference